Craft

Sensei Biotherapeutics

Stock Price

$0.6

2024-10-29

Market Capitalization

$14.8 M

2024-10-29

Sensei Biotherapeutics Summary

Company Summary

Overview
Sensei Biotherapeutics (formerly known as Panacea Pharmaceuticals) is a biotechnology company developing biologics therapies targeting key components of the immune system for the treatment of cancers. It offers a pipeline of immune-activating agents for an array of cancers including solid tumors and hematological malignancies.
Type
Public
Status
Active
Founded
1999
HQ
Boston, MA, US | view all locations
Website
https://www.senseibio.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • John K. Celebi

    John K. Celebi, President & Chief Executive Officer & Director

  • Erin Colgan

    Erin Colgan, Chief Financial Officer

  • Patrick Gallagher

    Patrick Gallagher, Chief Business Officer

  • Hanspeter Waldner

    Hanspeter Waldner, Senior Vice President, Head of Immunology & Translational Medicine

Operating MetricsView all

Patents (US)

4

Dec, 2020

Patents (Foreign)

2

Dec, 2020

Patent Applications (US)

5

Dec, 2020

LocationsView all

3 locations detected

  • Boston, MA HQ

    United States

    451 D St, Unit 710

  • Boston, MA

    United States

    6 Tide St

  • Rockville, MD

    United States

    1405 Research Blvd #125

Sensei Biotherapeutics Financials

Summary Financials

Net income (Q1, 2026)
($170.2M)
Cash (Q1, 2026)
$152.3M
EBIT (Q1, 2026)
($170.6M)
Enterprise value
($135.4M)

Footer menu